Post-market Clinical Follow-up Study Plan for Disposable Endoscopic Linear Cutter Stapler

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSuzhou Care-Real Medical Technology Co., Ltd.

About this trial

This study conducted a Post-Market Clinical Follow-Up study (PMCF) to evaluate the safety and effectiveness of the disposable endoscopic linear cutter stapler produced by Changzhou Ankang Medical Instrument Co., Ltd., through a retrospective analysis of the clinical data, to evaluate the safety and effectiveness of soft tissue resection, transection and anastomosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age unlimited and gender unlimited;

The surgery type shall be endoscopic surgery;

The departments of surgical procedures: general and thoracic surgical procedures;

Investigational devices of all the models of the staplers and its cartridge listed in Section 2.3.

Disqualifiers

Patients undergoing surgery for contraindications to the product, such as severe mucosal edema, non-observation of hemostatic sites for surgery or off-label use, such as liver and spleen;

Combined with other similar products (stapler) for resection, transection and anastomosis of the surgical site;

Surgery record is incomplete, unable to extract main indicators related information.

Trial population

For patients who need to be operated for abdominal, gynecologic, pediatric, and thoracic, endoscopic (i.e., endo-therapy) surgery for the expeditious transection/resection of tissues and creation of anastomoses.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Disposable endoscopic linear cutter stapler

    Device

    Investigational devices of all the models of the staplers and its cartridge listed in Study Plan(Plan number: CAK-PMCF)

Treatment groups

302 Participants
are divided into 1 treatment group
Group A: Disposable endoscopic linear cutter stapler1 intervention

Trial outcomes

Primary outcomes

1

Anastomosis success rate

The condition of no reoperation in situ was defined as successful anastomosis as determined by surgical records and hospitalization medical records.

Time frame
the investigation sites will be collected from January 2023 to September 2024.

Secondary outcomes

1

Operation time

Confirmed by surgical records and anesthesia sheets.

Time frame
The investigation sites will be collected from January 2023 to September 2024.
2

Amount of intraoperative blood loss

Confirmed by surgical records/nursing notes.

Time frame
the investigation sites will be collected from January 2023 to September 2024.
3

Intraoperative conversion (caused by the stapler and/or cartridge)

Surgical records confirm the intraoperative conversion, and determine whether the intraoperative conversion is caused by the investigational devices according to the description.

Time frame
the investigation sites will be collected from January 2023 to September 2024.
4

Length of hospitalization

Records were collected for the patient's date of surgery and date of discharge . Length of hospitalization(days) = date of discharge - date of surgery

Time frame
the investigation sites will be collected from January 2023 to September 2024.

Other outcomes

1

Adverse events

Common adverse events due to the device and treatment were: anastomotic leakage, bleeding, stenosis, fistula, infection, etc.

Time frame
From the date of surgery to six months after the surgery
2

Device deficiencies

Inadequacy of medical device with respect to its identity, quality, durability, reliability, usability, safety or performance.

Time frame
From the date of surgery to six months after the surgery
3

Serious adverse events

Incidence of serious adverse events = Number of serious adverse events/number of enrolled cases ×100%

Time frame
From the date of surgery to six months after the surgery

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Disposable endoscopic linear cutter stapler Status unavailable Wujin District, ChangzhouChinaChina

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: